Clidinium (Br)
Clidinium (Br) is antimuscarinic drug. Clidinium (Br) is used in the treatment of peptic ulcers. It slows the activity of the stomach and intestinal tract and relieves cramping and reduces acid secretion.
Primary Characteristics
It is of Synthetic origin and belongs to Quartenary Ammonium.
Molecular Weight: 432.4 · Solubility in Water: soluble · Solubility in Alcohol: soluble · Non-proprietary name: Clidinium (Br).
Pharmacokinetics
None recorded.
Advertisement
Indications
Clidinium (Br) is primarily indicated in conditions like Spasticity.
Clidinium (Br) is also indicated for secondary conditions like Peptic ulcer.
Contraindications
Clidinium (Br) is contraindicated in conditions like Hypersensitivity to any component of product.
Dosage
Clidinium (Br)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 3.75 mg | 3.75 mg | Every 6h | PO | |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Clidinium (Br) is known to cause more or less tolerable side effects which are usually transient. These include Cycloplegia, Dry mouth, Mydriasis, Urinary hesitancy, Xerostomia .
Warnings / Precautions
Interference in Pathology
Clidinium (Br) may interfere in the diagnosis of Serum Tests for Uric Acid .
Available Brands
Click on a strength to view available brands.
Multi-Ingredient Combinations
Storage Conditions
Drug Classification
- 1.17.5 — Antispasmodics
Manufacturers
Manufacturers of Clidinium (Br) in Pakistan: